Melissa M. Garrido
Icahn School of Medicine at Mount Sinai
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Melissa M. Garrido.
Health Services Research | 2014
Melissa M. Garrido; M.S.H.S. Amy S. Kelley M.D.; B A Julia Paris; B A Katherine Roza; Diane E. Meier; R. Sean Morrison; Melissa D. Aldridge
OBJECTIVES To model the steps involved in preparing for and carrying out propensity score analyses by providing step-by-step guidance and Stata code applied to an empirical dataset. STUDY DESIGN Guidance, Stata code, and empirical examples are given to illustrate (1) the process of choosing variables to include in the propensity score; (2) balance of propensity score across treatment and comparison groups; (3) balance of covariates across treatment and comparison groups within blocks of the propensity score; (4) choice of matching and weighting strategies; (5) balance of covariates after matching or weighting the sample; and (6) interpretation of treatment effect estimates. EMPIRICAL APPLICATION We use data from the Palliative Care for Cancer Patients (PC4C) study, a multisite observational study of the effect of inpatient palliative care on patient health outcomes and health services use, to illustrate the development and use of a propensity score. CONCLUSIONS Propensity scores are one useful tool for accounting for observed differences between treated and comparison groups. Careful testing of propensity scores is required before using them to estimate treatment effects.
Journal of Clinical Oncology | 2015
Peter May; Melissa M. Garrido; J. Brian Cassel; Amy S. Kelley; Diane E. Meier; Charles Normand; Thomas J. Smith; Lee Stefanis; R. Sean Morrison
PURPOSE Previous studies report that early palliative care is associated with clinical benefits, but there is limited evidence on economic impact. This article addresses the research question: Does timing of palliative care have an impact on its effect on cost? PATIENTS AND METHODS Using a prospective, observational design, clinical and cost data were collected for adult patients with an advanced cancer diagnosis admitted to five US hospitals from 2007 to 2011. The sample for economic evaluation was 969 patients; 256 were seen by a palliative care consultation team, and 713 received usual care only. Subsamples were created according to time to consult after admission. Propensity score weights were calculated, matching the treatment and comparison arms specific to each subsample on observed confounders. Generalized linear models with a γ distribution and a log link were applied to estimate the mean treatment effect on cost within subsamples. RESULTS Earlier consultation is associated with a larger effect on total direct cost. Intervention within 6 days is estimated to reduce costs by -
Health Services Research | 2012
Melissa M. Garrido; Partha Deb; James F. Burgess; Joan D. Penrod
1,312 (95% CI, -
Cancer | 2014
Melissa M. Garrido; Holly G. Prigerson
2,568 to -
Cancer | 2014
Melissa M. Garrido; Shannon T. Harrington; Holly G. Prigerson
56; P = .04) compared with no intervention and intervention within 2 days by -
Gerontologist | 2013
Melissa M. Garrido; Ellen L. Idler; Howard Leventhal; Deborah Carr
2,280 (95% CI, -
Journal of Pain and Symptom Management | 2014
Melissa M. Garrido
3,438 to -
Palliative Medicine | 2017
Peter May; Melissa M. Garrido; J. Brian Cassel; Amy S. Kelley; Diane E. Meier; Charles Normand; Thomas J. Smith; R. Sean Morrison
1,122; P < .001); these reductions are equivalent to a 14% and a 24% reduction, respectively, in cost of hospital stay. CONCLUSION Earlier palliative care consultation during hospital admission is associated with lower cost of hospital stay for patients admitted with an advanced cancer diagnosis. These findings are consistent with a growing body of research on quality and survival suggesting that early palliative care should be more widely implemented.
JAMA Internal Medicine | 2015
Katherine Ornstein; Melissa D. Aldridge; Melissa M. Garrido; Rebecca Gorges; Diane E. Meier; Amy S. Kelley
OBJECTIVE To compare methods of analyzing endogenous treatment effect models for nonlinear outcomes and illustrate the impact of model specification on estimates of treatment effects such as health care costs. DATA SOURCES Secondary data on cost and utilization for inpatients hospitalized in five Veterans Affairs acute care facilities in 2005-2006. STUDY DESIGN We compare results from analyses with full information maximum simulated likelihood (FIMSL); control function (CF) approaches employing different types and functional forms for the residuals, including the special case of two-stage residual inclusion; and two-stage least squares (2SLS). As an example, we examine the effect of an inpatient palliative care (PC) consultation on direct costs of care per day. DATA COLLECTION/EXTRACTION METHODS We analyzed data for 3,389 inpatients with one or more life-limiting diseases. PRINCIPAL FINDINGS The distribution of average treatment effects on the treated and local average treatment effects of a PC consultation depended on model specification. CF and FIMSL estimates were more similar to each other than to 2SLS estimates. CF estimates were sensitive to choice and functional form of residual. CONCLUSIONS When modeling cost or other nonlinear data with endogeneity, one should be aware of the impact of model specification and treatment effect choice on results.
Clinical Therapeutics | 2014
Melissa M. Garrido; Holly G. Prigerson; Joan D. Penrod; Shatice Jones; Kenneth S. Boockvar
The objective of the current study was to determine the best set of predictors of psychological disorders, regrets, health‐related quality of life, and mental health function among bereaved caregivers of patients with cancer, thereby identifying promising targets for interventions to improve bereavement adjustment.